[Asia Economy Reporter Baek Kyunghwan] InscoBi announced on the 26th that it will participate in a third-party allotment paid-in capital increase of its affiliate Cellumed with approximately 3 billion KRW to strengthen its bio business through equity expansion.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing